The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
The molecular regulation of Janus kinase (JAK) activation
Open accessAbstract
The JAK (Janus kinase) family members serve essential roles as the intracellular signalling effectors of cytokine receptors. This family, comprising JAK1, JAK2, JAK3 and TYK2 (tyrosine kinase 2), was first described more than 20 years ago, but the complexities underlying their activation, regulation and pleiotropic signalling functions are still being explored. Here, we review the current knowledge of their physiological functions and the causative role of activating and inactivating JAK mutations in human diseases, including haemopoietic malignancies, immunodeficiency and inflammatory diseases. At the molecular level, recent studies have greatly advanced our knowledge of the structures and organization of the component FERM (4.1/ezrin/radixin/moesin)-SH2 (Src homology 2), pseudokinase and kinase domains within the JAKs, the mechanism of JAK activation and, in particular, the role of the pseudokinase domain as a suppressor of the adjacent tyrosine kinase domain's catalytic activity. We also review recent advances in our understanding of the mechanisms of negative regulation exerted by the SH2 domain-containing proteins, SOCS (suppressors of cytokine signalling) proteins and LNK. These recent studies highlight the diversity of regulatory mechanisms utilized by the JAK family to maintain signalling fidelity, and suggest alternative therapeutic strategies to complement existing ATP-competitive kinase inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Self-citationJAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
Harrison, C., Kiladjian, J.-J., Al-Ali, H. K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D. S., Levy, R., Knoops, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110556 · Cited by 1,825
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408 · cited 1×
“The SOCS family members were initially discovered on the basis of their ability to bind JAK [106] and inhibit cytokine signalling [107, 108].”
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., Futreal, P. A., Erber, W. N., McMullin, M. F., Harrison, C. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065202 · Cited by 1,276
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220 · cited 1×
“An emerging idea is that nucleotide binding by pseudokinase domains may underlie or be indicative of a “molecular switch” mechanism [69, 70], although the physiological relevance of conformational switching amongst the JAK pseudokinase domains remains to be established.”
Self-citationSafety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Verstovsek, S., Kantarjian, H., Mesa, R. A., Pardanani, A. D., Cortes-Franco, J., Thomas, D. A., Estrov, Z., Fridman, J. S., Bradley, E. C., Erickson-Viitanen, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002028 · Cited by 1,164
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,038
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., & Pfeffer, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81168-x · Cited by 914
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Sheai, J. J., et al. (1995) · Nature · doi:10.1038/377065a0 · Cited by 877
A protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
DiSanto, J. P., Müller, W., Guy-Grand, D., Fischer, A., & Rajewsky, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.377 · Cited by 866
Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C. F., Yin, L., Pennica, D., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81166-6 · Cited by 853
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
Self-citationPTP1B Regulates Leptin Signal Transduction In Vivo
Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A., Haj, F., Wang, Y., Minokoshi, Y., Kim, Y.-B., Elmquist, J. K., Tartaglia, L. A., Kahn, B. B., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00148-x · Cited by 815
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 803
A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia
Lacronique, V., Boureux, A., Della Valle, V., Poirel, H., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 791
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771
Alexander, W. S., Starr, R., Fenner, J. E., Scott, C. L., Handman, E., Sprigg, N. S., Corbin, J. E., Cornish, A. L., Darwiche, R., Owczarek, C. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80047-1 · Cited by 762
Self-citationThe protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., et al. (1993) · Nature · doi:10.1038/366129a0 · Cited by 760
Twenty proteins containing a C-terminal SOCS box form five structural classes
Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D., & Nicola, N. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.114 · Cited by 733
Self-citationYasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719
Minegishi, Y., Saito, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.009 · Cited by 702
Mori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., Nishinakamura, H., Torisu, T., Chien, K. R., Yasukawa, H., & Yoshimura, A. (2004) · Nature Medicine · doi:10.1038/nm1071 · Cited by 651
Schindler, C., Fu, X. Y., Improta, T., Aebersold, R., & Darnell, J. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7836 · Cited by 647
Defective Lymphoid Development in Mice Lacking Jak3
Nosaka, T., van Deursen, J. M. A., Tripp, R. A., Thierfelder, W. E., Witthuhn, B. A., McMickle, A. P., Doherty, P. C., Grosveld, G. C., & Ihle, J. N. (1995) · Science · doi:10.1126/science.270.5237.800 · Cited by 637
JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
Dawson, M. A., Bannister, A. J., Göttgens, B., Foster, S. D., Bartke, T., Green, A. R., & Kouzarides, T. (2009) · Nature · doi:10.1038/nature08448 · Cited by 622
Identification of an Acquired JAK2 Mutation in Polycythemia Vera
Zhao, R., Xing, S., Li, Z., Fu, X., Li, Q., Krantz, S. B., & Zhao, Z. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500138200 · Cited by 615
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling
Irie-Sasaki, J., Sasaki, T., Matsumoto, W., Opavsky, A., Cheng, M., Welstead, G., Griffiths, E., Krawczyk, C., Richardson, C. D., Aitken, K., et al. (2001) · Nature · doi:10.1038/35053086 · Cited by 562
JAK mutations in high-risk childhood acute lymphoblastic leukemia
Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811761106 · Cited by 562
Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B
Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., Kennedy, B. P., & Tremblay, M. L. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00149-1 · Cited by 546
Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3
Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H., & Berg, L. J. (1995) · Science · doi:10.1126/science.270.5237.794 · Cited by 537
Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., et al. (1993) · Nature · doi:10.1038/366166a0 · Cited by 533
Wilks, A. F., Harpur, A. G., Kurban, R. R., Ralph, S. J., Zürcher, G., & Ziemiecki, A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.2057 · Cited by 528
Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H., et al. (1997) · Blood · doi:10.1182/blood.v90.7.2535 · Cited by 491
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
Park, S. Y., Saijo, K., Takahashi, T., Osawa, M., Areas, H., Hirayama, N., Miyake, K., Nakauchi, H., Shirasawa, T., & Saito, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90066-7 · Cited by 487
TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B
Myers, M. P., Andersen, J. N., Cheng, A., Tremblay, M. L., Horvath, C. M., Parisien, J.-P., Salmeen, A., Barford, D., & Tonks, N. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100583200 · Cited by 474
Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction
Wilks, A. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1603 · Cited by 424
Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice
Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H., McCoy, B., Bogdan, C., Decker, T., Brem, G., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00054-6 · Cited by 420
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Brooks, A. J., Dai, W., O’Mara, M. L., Abankwa, D., Chhabra, Y., Pelekanos, R. A., Gardon, O., Tunny, K. A., Blucher, K. M., Morton, C. J., et al. (2014) · Science · doi:10.1126/science.1249783 · Cited by 418
Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00263.x · Cited by 398
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Chan, R. J., & Feng, G.-S. (2007) · Blood · doi:10.1182/blood-2006-07-028829 · Cited by 371
Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
Koppikar, P., Bhagwat, N., Kilpivaara, O., Manshouri, T., Adli, M., Hricik, T., Liu, F., Saunders, L. M., Mullally, A., Abdel-Wahab, O., et al. (2012) · Nature · doi:10.1038/nature11303 · Cited by 370
Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3387-3395.2000 · Cited by 365
You, M., Yu, D.-H., & Feng, G.-S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2416 · Cited by 364
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshäuser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., et al. (2003) · Nature Immunology · doi:10.1038/ni910 · Cited by 361
Feng, J., Witthuhn, B. A., Matsuda, T., Kohlhuber, F., Kerr, I. M., & Ihle, J. N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2497 · Cited by 356
The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3
Simoncic, P. D., Lee-Loy, A., Barber, D. L., Tremblay, M. L., & McGlade, C. J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00697-8 · Cited by 351
David, M., Chen, H. E., Goelz, S., Larner, A. C., & Neel, B. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.7050 · Cited by 342
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61341-0 · Cited by 337
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
Flex, E., Petrangeli, V., Stella, L., Chiaretti, S., Hornakova, T., Knoops, L., Ariola, C., Fodale, V., Clappier, E., Paoloni, F., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072182 · Cited by 334
Oh, S. T., Simonds, E. F., Jones, C., Hale, M. B., Goltsev, Y., Gibbs, K. D., Merker, J. D., Zehnder, J. L., Nolan, G. P., & Gotlib, J. (2010) · Blood · doi:10.1182/blood-2010-02-270108 · Cited by 330
(1990) · PubMed · Cited by 322
Shimoda, K., Kato, K., Aoki, K., Matsuda, T., Miyamoto, A., Shibamori, M., Yamashita, M., Numata, A., Takase, K., Kobayashi, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00055-8 · Cited by 319
Saharinen, P., & Silvennoinen, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205156200 · Cited by 318
Activating alleles of JAK3 in acute megakaryoblastic leukemia
Walters, D. K., Mercher, T., Gu, T.-L., O'Hare, T., Tyner, J. W., Loriaux, M., Goss, V. L., Lee, K. A., Eide, C. A., Wong, M. J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.002 · Cited by 317
Kawamura, M., McVicar, D. W., Johnston, J. A., Blake, T. B., Chen, Y. Q., Lal, B. K., Lloyd, A. R., Kelvin, D. J., Staples, J. E., Ortaldo, J. R., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6374 · Cited by 302
Kershaw, N. J., Murphy, J. M., Liau, N. P. D., Varghese, L. N., Laktyushin, A., Whitlock, E. L., Lucet, I. S., Nicola, N. A., & Babon, J. J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2519 · Cited by 301
Self-citationPlacental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
Roberts, A. W., Robb, L., Rakar, S., Hartley, L., Cluse, L., Nicola, N. A., Metcalf, D., Hilton, D. J., & Alexander, W. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161271798 · Cited by 300
Self-citationLiu, B. A., Jablonowski, K., Raina, M., Arcé, M., Pawson, T., & Nash, P. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.001 · Cited by 294
Jiao, H., Berrada, K., Yang, W., Tabrizi, M., Platanias, L. C., & Yi, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6985 · Cited by 289
SOCS3 Is a Critical Physiological Negative Regulator of G-CSF Signaling and Emergency Granulopoiesis
Croker, B. A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., DiRago, L., Cluse, L. A., Sutherland, K. D., Hartley, L., Williams, E., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00022-6 · Cited by 285
Self-citationBabon, J. J., Kershaw, N. J., Murphy, J. M., Varghese, L. N., Laktyushin, A., Young, S. N., Lucet, I. S., Norton, R. S., & Nicola, N. A. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.015 · Cited by 279
Self-citationZhang, J., Mullighan, C. G., Harvey, R. C., Wu, G., Chen, X., Edmonson, M., Buetow, K. H., Carroll, W. L., Chen, I.-M., Devidas, M., et al. (2011) · Blood · doi:10.1182/blood-2011-03-341412 · Cited by 277
Ungureanu, D., Wu, J., Pekkala, T., Niranjan, Y., Young, C., Jensen, O. N., Xu, C.-F., Neubert, T. A., Skoda, R. C., Hubbard, S. R., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2099 · Cited by 276
A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties
Murphy, J. M., Zhang, Q., Young, S. N., Reese, M. L., Bailey, F. P., Eyers, P. A., Ungureanu, D., Hammaren, H., Silvennoinen, O., Varghese, L. N., et al. (2014) · Biochemical Journal · doi:10.1042/bj20131174 · Cited by 276
Self-citationPilati, C., Letouzé, E., Nault, J.-C., Imbeaud, S., Boulai, A., Calderaro, J., Poussin, K., Franconi, A., Couchy, G., Morcrette, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.005 · Cited by 272
The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2
Reiter, A., Walz, C., Watmore, A., Schoch, C., Blau, I., Schlegelberger, B., Berger, U., Telford, N., Aruliah, S., Yin, J. A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4263 · Cited by 269
Lucet, I. S., Fantino, E., Styles, M., Bamert, R., Patel, O., Broughton, S. E., Walter, M., Burns, C. J., Treutlein, H., Wilks, A. F., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2413 · Cited by 266
Self-citationWagner, K.-U., Krempler, A., Triplett, A. A., Qi, Y., George, N. M., Zhu, J., & Rui, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5510-5520.2004 · Cited by 247
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246
Chim, C.-S., Fung, T.-K., Cheung, W.-C., Liang, R., & Kwong, Y.-L. (2004) · Blood · doi:10.1182/blood-2003-06-2007 · Cited by 246
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
Bandaranayake, R. M., Ungureanu, D., Shan, Y., Shaw, D. E., Silvennoinen, O., & Hubbard, S. R. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2348 · Cited by 240
Passamonti, F., Elena, C., Schnittger, S., Skoda, R. C., Green, A. R., Girodon, F., Kiladjian, J.-J., McMullin, M. F., Ruggeri, M., Besses, C., et al. (2011) · Blood · doi:10.1182/blood-2010-11-316810 · Cited by 236
Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice
Velazquez, L., Cheng, A. M., Fleming, H. E., Furlonger, C., Vesely, S., Bernstein, A., Paige, C. J., & Pawson, T. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011883 · Cited by 232
Lupardus, P. J., Ultsch, M., Wallweber, H., Bir Kohli, P., Johnson, A. R., & Eigenbrot, C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401180111 · Cited by 229
Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052333 · Cited by 225
STATs Dimerize in the Absence of Phosphorylation
Braunstein, J., Brutsaert, S., Olson, R., & Schindler, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304531200 · Cited by 209
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways
Tong, W., Zhang, J., & Lodish, H. F. (2005) · Blood · doi:10.1182/blood-2004-10-4093 · Cited by 207
Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
Jeong, E. G., Kim, M. S., Nam, H. K., Min, C. K., Lee, S., Chung, Y. J., Yoo, N. J., & Lee, S. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4839 · Cited by 201
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
Kleppe, M., Lahortiga, I., El Chaar, T., De Keersmaecker, K., Mentens, N., Graux, C., Van Roosbroeck, K., Ferrando, A. A., Langerak, A. W., Meijerink, J. P. P., et al. (2010) · Nature Genetics · doi:10.1038/ng.587 · Cited by 198
Ema, H., Sudo, K., Seita, J., Matsubara, A., Morita, Y., Osawa, M., Takatsu, K., Takaki, S., & Nakauchi, H. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.03.019 · Cited by 197
Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice
Krempler, A., Qi, Y., Triplett, A. A., Zhu, J., Rui, H., & Wagner, K. (2004) · genesis · doi:10.1002/gene.20063 · Cited by 195
Bersenev, A., Wu, C., Balcerek, J., & Tong, W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35808 · Cited by 183
Loh, M. L., Zhang, J., Harvey, R. C., Roberts, K., Payne-Turner, D., Kang, H., Wu, G., Chen, X., Becksfort, J., Edmonson, M., et al. (2013) · Blood · doi:10.1182/blood-2012-04-422691 · Cited by 177
Lnk Inhibits Tpo–mpl Signaling and Tpo-mediated Megakaryocytopoiesis
Tong, W., & Lodish, H. F. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040762 · Cited by 174
Structural basis of recognition of interferon-α receptor by tyrosine kinase 2
Wallweber, H. J. A., Tam, C., Franke, Y., Starovasnik, M. A., & Lupardus, P. J. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2807 · Cited by 165
Babon, J. J., McManus, E. J., Yao, S., DeSouza, D. P., Mielke, L. A., Sprigg, N. S., Willson, T. A., Hilton, D. J., Nicola, N. A., Baca, M., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.024 · Cited by 163
Self-citationSevere defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency
Shultz, L. D., Rajan, T. V., & Greiner, D. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01060-3 · Cited by 163
Huang, X., Li, Y., Tanaka, K., Moore, K. G., & Hayashi, J. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11618 · Cited by 158
Seita, J., Ema, H., Ooehara, J., Yamazaki, S., Tadokoro, Y., Yamasaki, A., Eto, K., Τακακι, S., Takatsu, K., & Nakauchi, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606238104 · Cited by 157
JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
Rane, S. G., & Reddy, E. P. (1994) · PubMed · Cited by 148
Griesinger, F., Hennig, H., Hillmer, F., Podleschny, M., Steffens, R., Pies, A., Wormann, B. J., Haase, D. T., & Bohlander, S. K. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20235 · Cited by 148
JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri, B., Kovanen, P., Sasaki, A., Yoshimura, A., & Leonard, W. (2001) · Blood · doi:10.1182/blood.v97.1.221 · Cited by 148
Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its Activity
Argetsinger, L. S., Kouadio, J.-L. K., Steen, H., Stensballe, A., Jensen, O. N., & Carter‐Su, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4955-4967.2004 · Cited by 146
Wernig, G., Gonneville, J. R., Crowley, B. J., Rodrigues, M. S., Reddy, M., Hudon, H. E., Walz, C., Reiter, A., Podar, K., Royer, Y., et al. (2008) · Blood · doi:10.1182/blood-2007-07-102186 · Cited by 145
Dimerization by a Cytokine Receptor Is Necessary for Constitutive Activation of JAK2V617F
Lu, X., Huang, L. J.-S., & Lodish, H. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707125200 · Cited by 141
Control of B Cell Production by the Adaptor Protein Lnk
Τακακι, S., Sauer, K., Iritani, B. M., Chien, S., Ebihara, Y., Tsuji, K., Takatsu, K., & Perlmutter, R. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00060-1 · Cited by 139
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
Lund, I. K., Hansen, J. A., Andersen, H. S., Møller, N. P. H., & Billestrup, N. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01694 · Cited by 139
Buza-Vidas, N., Antonchuk, J., Qian, H., Månsson, R., Luc, S., Zandi, S., Anderson, K., Τακακι, S., Nygren, J., Jensen, C. T., et al. (2006) · Genes & Development · doi:10.1101/gad.385606 · Cited by 138
Shaw, M. H., Boyartchuk, V., Wong, S., Karaghiosoff, M., Ragimbeau, J., Pellegrini, S., Müller, M. M., Dietrich, W. F., & Yap, G. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1930781100 · Cited by 136
Yin, T., Shen, R., Feng, G., & Yang, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1032 · Cited by 135
Myers, F. A., Evans, D. R., Clayton, A. L., Thorne, A. W., & Crane‐Robinson, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009472200 · Cited by 135
Jak3 and the pathogenesis of severe combined immunodeficiency
OASHEA, J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.014 · Cited by 130
Tyrosine Phosphorylation of Jak2 in the JH2 Domain Inhibits Cytokine Signaling
Feener, E. P., Rosario, F., Dunn, S. L., Stancheva, Z. S., & Myers, M. G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4968-4978.2004 · Cited by 129
Musso, T., Johnston, J. A., Linnekin, D., Varesio, L., Rowe, T. K., O’Shea, J. J., & McVicar, D. W. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1425 · Cited by 125
Yetter, A., Shahab Uddin, M. S., Krolewski, J. J., Jiao, H., Yi, T., & Platanias, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18179 · Cited by 124
Bousquet, M., Quelen, C., Mas, V. M., Duchayne, É., Roquefeuil, B., Delsol, G., Laurent, G., Dastugue, N., & Brousset, P. (2005) · Oncogene · doi:10.1038/sj.onc.1208850 · Cited by 122
The biology and mechanism of action of Suppressor of Cytokine Signaling 3 (SOCS3)
Babon, J., & Nicola, N. (2012) · Growth Factors · doi:10.3109/08977194.2012.687375 · Cited by 121
Self-citationMutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia
Porcu, M., Kleppe, M., Gianfelici, V., Geerdens, E., Keersmaecker, K. D., Tartaglia, M., Foà, R., Soulier, J., Cauwelier, B., Uyttebroeck, A., et al. (2012) · Blood · doi:10.1182/blood-2011-09-379958 · Cited by 120
Kretzschmar, A. K., Dinger, M. C., Henze, C., Brocke-Heidrich, K., & Horn, F. (2004) · Biochemical Journal · doi:10.1042/bj20030708 · Cited by 114
Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases
Toms, A. V., Deshpande, A. J., McNally, R., Jeong, Y., Rogers, J. M., Kim, C. U., Gruner, S. M., Ficarro, S. B., Marto, J. A., Sattler, M., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2673 · Cited by 114
A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome
Kılıç, S. Ş., HACIMUSTAFAOĞLU, M. K., Boisson‐Dupuis, S., Kreins, A. Y., Grant, A. V., Abel, L., & Casanova, J. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.056 · Cited by 108
Tyrosine 813 Is a Site of JAK2 Autophosphorylation Critical for Activation of JAK2 by SH2-Bβ
Kurzer, J. H., Argetsinger, L. S., Zhou, Y.-J., Kouadio, J.-L. K., O’Shea, J. J., & Carter‐Su, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4557-4570.2004 · Cited by 108
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
Kleppe, M., Soulier, J., Asnafi, V., Mentens, N., Hornakova, T., Knoops, L., Constantinescu, S. N., Sigaux, F., Meijerink, J. P. P., Vandenberghe, P., et al. (2011) · Blood · doi:10.1182/blood-2010-10-314286 · Cited by 100
Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem Cells
Akada, H., Akada, S., Hutchison, R. E., Sakamoto, K., Wagner, K., & Mohi, G. (2014) · Stem Cells · doi:10.1002/stem.1711 · Cited by 97
Lupardus, P. J., Skiniotis, G., Rice, A. J., Thomas, C., Fischer, S., Walz, T., & García, K. C. (2011) · Structure · doi:10.1016/j.str.2010.10.010 · Cited by 95
Tauchi, T., Damen, J. E., Toyama, K., Feng, G., Broxmeyer, H., & Krystal, G. (1996) · Blood · doi:10.1182/blood.v87.11.4495.bloodjournal87114495 · Cited by 95
Dusa, A., Mouton, C., Pecquet, C., Herman, M., & Constantinescu, S. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011157 · Cited by 94
Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
Ma, W., Kantarjian, H. M., Zhang, X., Yeh, C.-H., Zhang, Z. J., Verstovšek, S., & Albitar, M. X. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080114 · Cited by 91
Funakoshi-Tago, M., Pelletier, S., Matsuda, T., Parganas, E., & Ihle, J. (2006) · EMBO Journal · doi:10.1038/sj.emboj.7601365 · Cited by 89
The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3
Vogt, M., Domoszlai, T., Kleshchanok, D., Lehmann, S., Schmitt, A., Poli, V., Richtering, W., & Müller-Newen, G. (2011) · Journal of Cell Science · doi:10.1242/jcs.072520 · Cited by 80
Constitutive nuclear localization of Janus kinases 1 and 2
Lobie, P. E., Ronsin, B., Silvennoinen, O., Haldosén, L., Norstedt, G., & Morel, G. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756581 · Cited by 79
Bone, H., Dechert, U., Jirik, F. R., Schrader, J. W., & Welham, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14470 · Cited by 72
Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia
Kratz, C., Böll, S., Kontny, U., Schrappe, M., Niemeyer, C. M., & Stanulla, M. (2005) · Leukemia · doi:10.1038/sj.leu.2404060 · Cited by 68
Phosphorylation of Jak2 on Ser 523 InhibitsJak2-Dependent Leptin ReceptorSignaling
Ishida-Takahashi, R., Rosario, F., Gong, Y., Kopp, K., Stancheva, Z. S., Chen, X., Feener, E. P., & Myers, M. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01589-05 · Cited by 65
JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth
Zouein, F. A., Duhé, R. J., & Booz, G. W. (2011) · Growth Factors · doi:10.3109/08977194.2011.614949 · Cited by 64
Park, S. O., Wamsley, H. L., Bae, K., Hu, Z., Li, X., Choe, S., Slayton, W. B., Oh, S. P., Wagner, K., & Sayeski, P. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059675 · Cited by 63
SH2-B Family Members Differentially Regulate JAK Family Tyrosine Kinases
O’Brien, K. B., O’Shea, J. J., & Carter‐Su, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109165200 · Cited by 63
Mazurkiewicz-Muñoz, A. M., Argetsinger, L. S., Kouadio, J.-L. K., Stensballe, A., Jensen, O. N., Cline, J. M., & Carter‐Su, C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01591-05 · Cited by 63
Baran‐Marszak, F., Magdoud, H., Desterke, C., Alvarado‐Navarro, A., Roger, C., Harel, S., Mazoyer, E., Cassinat, B., Chevret, S., Tonetti, C., et al. (2010) · Blood · doi:10.1182/blood-2009-12-256768 · Cited by 62
PTP1B Suppresses Prolactin Activation of Stat5 in Breast Cancer Cells
Johnson, K. J., Peck, A. R., Liu, C., Tran, T. H., Utama, F. E., Sjolund, A. B., Schaber, J. D., Witkiewicz, A. K., & Rui, H. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090399 · Cited by 57
Babon, J. J., Yao, S., DeSouza, D. P., Harrison, C. F., Fabri, L., Liepinsh, E., Scrofani, S. D. B., Baca, M., & Norton, R. S. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05010.x · Cited by 55
Self-citationBullen, D. V. R., Darwiche, R., Metcalf, D., Handman, E., & Alexander, W. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01294.x · Cited by 53
Determination of the transphosphorylation sites of Jak2 kinase
Matsuda, T., Feng, J., Witthuhn, B. A., Sekine, Y., & Ihle, J. N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.071 · Cited by 53
Grisouard, J., Hao-Shen, H., Dirnhofer, S., Wagner, K., & Skoda, R. C. (2014) · Haematologica · doi:10.3324/haematol.2013.100016 · Cited by 50
Regulation of Jak2 Function by Phosphorylation of Tyr317 and Tyr637 during Cytokine Signaling
Robertson, S., Koleva, R., Argetsinger, L. S., Carter‐Su, C., Marto, J. A., Feener, E. P., & Myers, M. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00278-09 · Cited by 46
A JAK2 Interdomain Linker Relays Epo Receptor Engagement Signals to Kinase Activation
Lequn, Z., Dong, H., Zhang, C. C., Kinch, L. N., Osawa, M., Iacovino, M., Grishin, N. V., Kyba, M., & Huang, L. J.-S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011387 · Cited by 45
Kurzer, J. H., Saharinen, P., Silvennoinen, O., & Carter‐Su, C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00570-06 · Cited by 45
Argetsinger, L. S., Stuckey, J. A., Robertson, S., Koleva, R., Cline, J. M., Marto, J. A., Myers, M. G., & Carter‐Su, C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0355 · Cited by 39
Varghese, L. N., Ungureanu, D., Liau, N. P. D., Young, S. N., Laktyushin, A., Hammarén, H. M., Lucet, I. S., Nicola, N. A., Silvennoinen, O., Babon, J. J., et al. (2013) · Biochemical Journal · doi:10.1042/bj20131516 · Cited by 39
Self-citationGodeny, M. D., Sayyah, J., VonDerLinden, D., Johns, M., Ostrov, D. A., Caldwell-Busby, J., & Sayeski, P. P. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.08.010 · Cited by 36
Gorantla, S. P., Dechow, T. N., Grundler, R., Illert, A. L., Büschenfelde, C. M. Z., Kremer, M., Peschel, C., & Duyster, J. (2010) · Blood · doi:10.1182/blood-2009-07-236133 · Cited by 30
Funakoshi‐Tago, M., Tago, K., Kasahara, T., Parganas, E., & Ihle, J. N. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.07.008 · Cited by 25
Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance
Vielnascher, R. M., Hainzl, E., Leitner, N. R., Rammerstorfer, M., Popp, D., Witalisz‐Siepracka, A., Rom, R., Karaghiosoff, M., Kolbe, T., Müller, S., et al. (2014) · Transgenic Research · doi:10.1007/s11248-014-9795-y · Cited by 21
Louria‐Hayon, I., Frelin, C., Ruston, J., Gish, G. D., Jin, J., Kofler, M., Lambert, J., Adissu, H. A., Milyavsky, M., Herrington, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319665110 · Cited by 18
On the Regulation and Activation of JAK2: A Novel Hypothetical Model
Lee, T. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0555 · Cited by 8
Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms
Godfrey, A. L., & Green, A. R. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.07.003 · Cited by 7
Cited by
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017) · Drugs · doi:10.1007/s40265-017-0701-9 · Cited by 1,206
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017) · Drugs · doi:10.1007/s40265-017-0736-y · Cited by 590
Simpson, E. L., Sinclair, R., Forman, S., Wollenberg, A., Aschoff, R., Cork, M., Bieber, T., Thyssen, J. P., Yosipovitch, G., Flohr, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30732-7 · Cited by 522
Silverberg, J. I., Simpson, E. L., Thyssen, J. P., Gooderham, M., Chan, G., Feeney, C., Biswas, P., Valdez, H., DiBonaventura, M., Nduaka, C., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1406 · Cited by 404
Metadata
- Authors
- Babon, J. J., Lucet, I. S., Murphy, J. M., Nicola, N. A., & Varghese, L. N.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2014-07-24
- Volume
- 462
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2086221920
- Cited by
- 326
- References
- 158
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.